Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine

BMC Neurology
A V Krymchantowski, Marcelo Bigal

Abstract

Rizatriptan is an effective and fast acting drug for the acute treatment of migraine. Some nonsteroidal anti-inflammatory drugs (NSAID) have also demonstrated efficacy in treating migraine attacks. There is evidence that the combination of a triptan and a NSAID decreases migraine recurrence in clinical practice. The primary aim of this randomized open label study was to assess the recurrence rates in migraine sufferers acutely treated with rizatriptan (RI) alone vs. rizatriptan plus a COX-2 enzyme inhibitor (rofecoxib, RO) vs. rizatriptan plus a traditional NSAID (tolfenamic acid, TO). We were also interested in comparing the efficacy rates within these three groups. We assessed 45 patients from a headache clinic in Rio de Janeiro (35 women and 10 men, ages 18 to 65 years, mean 37 years). Patients with IHS migraine were randomized to one out of 3 groups, where they had to treat 6 consecutive moderate or severe attacks in counterbalanced order. In group 1, patients treated the first two attacks with 10 mg RI, the third and fourth attacks with RI + 50 mg RO and the last attacks with RI + 200 mg of TA. In group 2, we began with RI + TA, followed by RI, and RI + RO. Group 3 treated in the following order: RI + RO, RI + TA, RI alone...Continue Reading

References

Aug 18, 1979·Lancet·H HakkarainenJ Parantainen
Jun 1, 1996·Gastroenterology Clinics of North America·J L MasferrerK Seibert
Mar 20, 1998·Headache·S J Peroutka
May 11, 1999·Cephalalgia : an International Journal of Headache·A V KrymchantowskiD Fernandes
Dec 2, 1999·JAMA : the Journal of the American Medical Association·M J LangmanT J Simon
Dec 28, 1999·Brain : a Journal of Neurology·P Tfelt-HansenP J Goadsby
Mar 9, 2000·American Journal of Epidemiology·M R GriffinW A Ray
Aug 2, 2000·Arquivos de neuro-psiquiatria·A V Krymchantowski
Nov 23, 2000·The New England Journal of Medicine·C BombardierUNKNOWN VIGOR Study Group
Apr 12, 2001·Arquivos de neuro-psiquiatria·A V KrymchantowskiL A Alves
Jul 9, 2002·Cephalalgia : an International Journal of Headache·A V Krymchantowski, J S Barbosa
Oct 18, 2002·Cephalalgia : an International Journal of Headache·M D FerrariR B Lipton
Feb 6, 2004·Headache·Randal L Von SeggernJames U Adelman
Dec 15, 2004·Cephalalgia : an International Journal of Headache·Mja Láinez
Jun 15, 2005·Headache·Randolph W EvansRogelio Leira
Jun 19, 2013·Cephalalgia : an International Journal of Headache·UNKNOWN Headache Classification Committee of the International Headache Society (IHS)

❮ Previous
Next ❯

Citations

Jan 16, 2009·Bulletin of Experimental Biology and Medicine·A Yu Dvorzhak
Nov 3, 2009·Academic Medicine : Journal of the Association of American Medical Colleges·Jim Bizzocchi, Robyn Schell
Aug 19, 2011·American Journal of Nephrology·Dilinaer BolatiToshimitsu Niwa
Jun 11, 2010·Journal of Neurogastroenterology and Motility·Uday C GhoshalAsha Misra
May 29, 2014·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Gianni AllaisChiara Benedetto
Sep 2, 2008·Expert Review of Neurotherapeutics·Catalina Cleves, Stewart J Tepper
Apr 28, 2005·Expert Review of Neurotherapeutics·Abouch Valenty Krymchantowski
May 1, 2009·Expert Review of Neurotherapeutics·Marcelo E BigalRichard Hargreaves
Aug 20, 2005·Headache·Timothy R SmithW James Alexander
Nov 3, 2006·Headache·Joel R SaperAlan Rapoport
Nov 23, 2006·Headache·Michael J Drescher, Yonatan Elstein
Jul 11, 2014·Expert Opinion on Pharmacotherapy·Stephen D Silberstein, Jessica C Stirpe
Oct 12, 2010·The Journal of Headache and Pain·Anders Hougaard, Peer Tfelt-Hansen
May 18, 2012·The Journal of Headache and Pain·Paola SarchielliGiorgio Zanchin
Dec 14, 2016·The Journal of Headache and Pain·Haiyang XuMingxian Li
Jul 23, 2008·Cephalalgia : an International Journal of Headache·J SchoenenUNKNOWN Belgian Headache Society
Jan 25, 2017·Scientia pharmaceutica·Mercè CánovasFrancesc Cabré
Apr 28, 2005·Expert Review of Neurotherapeutics·Abouch Valenty Krymchantowski, Marcelo Eduardo Bigal
Jan 30, 2009·Headache·Richard J HargreavesFred D Sheftell
Mar 15, 2006·Expert Review of Neurotherapeutics·Abouch Valenty Krymchantowski, Marcelo Eduardo Bigal
Sep 1, 2006·Neuropsychiatric Disease and Treatment·Abouch Valenty Krymchantowski
Jul 25, 2014·Expert Review of Neurotherapeutics·Gianni AllaisChiara Benedetto
Feb 11, 2015·Headache·Marcelo Moraes ValençaCarlos Alberto Bordini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.